0001567619-20-000851.txt : 20200110 0001567619-20-000851.hdr.sgml : 20200110 20200110105519 ACCESSION NUMBER: 0001567619-20-000851 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 EFFECTIVENESS DATE: 20200110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tacitus Therapeutics Inc. CENTRAL INDEX KEY: 0001799226 IRS NUMBER: 844056421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-357655 FILM NUMBER: 20519924 BUSINESS ADDRESS: STREET 1: C/O SUMMER ROAD LLC STREET 2: 207 6TH STREET CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 332-333-4315 MAIL ADDRESS: STREET 1: C/O SUMMER ROAD LLC STREET 2: 207 6TH STREET CITY: WEST PALM BEACH STATE: FL ZIP: 33401 D 1 primary_doc.xml X0708 D LIVE 0001799226 Tacitus Therapeutics Inc. C/O SUMMER ROAD LLC 207 6TH STREET WEST PALM BEACH FL FLORIDA 33401 332-333-4315 DELAWARE None None Corporation true 2019 Carter Cliff 13250 West Letts Lane Carmel IN INDIANA 46074 Executive Officer Director Jeffrey Kennedy C/O SUMMER ROAD LLC 207 6TH STREET WEST PALM BEACH FL FLORIDA 33401 Executive Officer Director Thomas Novak C/O SUMMER ROAD LLC 207 6TH STREET WEST PALM BEACH FL FLORIDA 33401 Director Erik Lium c/o Ichan School of Medicine at Mt Sinai One Gustave L. Levy Place New York NY NEW YORK 10029 Director Pharmaceuticals Decline to Disclose 06c false 2019-12-31 true true false 2000 10002000 5002000 5000000 One investor was issued securities in consideration of the granting of an exclusive license from such investor to the issuer. false 2 0 0 0 false Tacitus Therapeutics Inc. /s/ Carter Cliff Carter Cliff Chief Executive Officer 2020-01-10